Bli medlem
Bli medlem

Du är här


Hofseth Biocare ASA: Expiry of subscription period and last day of trading in subscription rights 17 October 2016


(Oslo, Norway, 14 October 2016) Reference is made to the stock exchange
announcement dated 30 September 2016 and the prospectus dated 30 September
2016 (the "Prospectus") concerning, inter alia, the subsequent offering (the
"Subsequent Offering") of minimum 1 and maximum 13,333,334 new shares (the
"Offer Shares") in Hofseth BioCare ASA ("HBC" or the "Company", ticker
"HBC"). The subscription price in the Subsequent Offering is NOK 1.50, equal
to the subscription price in the NOK 165.4 million private placements
completed on 20 September 2016.

Subscription rights for participation in the Subsequent Offering can be
exercised during the ongoing subscription period, which will expire Monday,
17 October 2016, at 16:30 CET.

The period for trading in subscription rights (ticker "HBC-T") for the
Subsequent Offering will also expire Monday, 17 October 2016 at 16:30 CET.

Subscription Rights that are not exercised before the end of the subscription
period will have no value and will lapse without compensation to the holder.
Holders of Subscription Rights should note that subscriptions for Offer
Shares must be made in accordance with the procedures set out in the
Prospectus and that holding Subscription Rights in itself does not represent
a subscription for Offer Shares.

You are strongly encouraged to read the Prospectus carefully before deciding
if you would like to subscribe in the Subsequent Offering. The Prospectus and
the subscription form for the Subsequent Offering is available electronically
at and in hard copy at the Company's premises at
Molovegen 6, 6004 Ålesund, Norway. The form can be downloaded from this URL:

For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966

About Hofseth BioCare ASA:
HBC is a Norwegian biotech company that offers high-value ingredients and
finished products for humans and pets. The company is founded on the core
values of sustainability, traceability and optimal utilization of natural
resources. Through an innovative hydrolysis technology, HBC is able to
preserve the quality of salmon oil, proteins and calcium, prepared of fresh
salmon off-cuts. HBC's objective is to contribute to the efficient use of
marine resources and deliver quality products for ingredients and finished
consumer products in the nutrition market.

Hofseth BioCare's headquarters are located in Ålesund, Norway with branches in
Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange Axess
list with ticker "HBC". More information about Hofseth BioCare at

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.